P53-dependent Inhibition of FKHRL1 in Response to DNA Damage Through Protein Kinase SGK1
Overview
Authors
Affiliations
FKHRL1 (FOXO3a) and p53 are two potent stress-response regulators. Here we show that these two transcription factors exhibit "crosstalk" in vivo. In response to DNA damage, p53 activation led to FKHRL1 phosphorylation and subcellular localization change, which resulted in inhibition of FKHRL1 transcription activity. AKT was dispensable for p53-dependent suppression of FKHRL1. By contrast, serum- and glucocorticoid-inducible kinase 1 (SGK1) was significantly induced in a p53-dependent manner after DNA damage, and this induction was through extracellular signal-regulated kinase 1/2-mediated posttranslational regulation. Furthermore, inhibition of SGK1 expression by a small interfering RNA knockdown experiment significantly decreased FKHRL1 phosphorylation in response to DNA damage. Taken together, our observations reveal previously unrecognized crosstalk between p53 and FKHRL1. Moreover, our findings suggest a new pathway for understanding aging and the age dependency of human diseases governed by these two transcription factors.
The Roles of Forkhead Box O3a (FOXO3a) in Bone and Cartilage Diseases - A Narrative Review.
Wu Z, Zhan W, Wu L, Yu L, Xie X, Yu F Drug Des Devel Ther. 2025; 19:1357-1375.
PMID: 40034405 PMC: 11874768. DOI: 10.2147/DDDT.S494841.
Ribeiro C, Ferreirinha P, Landry J, Macedo F, Sousa L, Pinto R Cell Death Dis. 2024; 15(5):352.
PMID: 38773063 PMC: 11109193. DOI: 10.1038/s41419-024-06728-0.
FOXO3a-interacting proteins' involvement in cancer: a review.
Dong Z, Guo Z, Li H, Han D, Xie W, Cui S Mol Biol Rep. 2024; 51(1):196.
PMID: 38270719 DOI: 10.1007/s11033-023-09121-w.
Li J, Yu H, Wang X, Ye Y, Fang W, Ding N Cancer Control. 2022; 29:10732748221143881.
PMID: 36519740 PMC: 9761230. DOI: 10.1177/10732748221143881.
Molecular Mechanisms of Autophagy in Cancer Development, Progression, and Therapy.
Vitto V, Bianchin S, Zolondick A, Pellielo G, Rimessi A, Chianese D Biomedicines. 2022; 10(7).
PMID: 35884904 PMC: 9313210. DOI: 10.3390/biomedicines10071596.